Innocan Pharma Corp
F:IP4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Innocan Pharma Corp
F:IP4
|
IL |
|
Barsele Minerals Corp
XTSX:BME
|
CA |
Multiples-Based Value
The Multiples-Based Value for Innocan Pharma Corp (IP4) under the Base Case is 18.28 EUR. Compared with the current market price of 11.7 EUR, the stock appears Undervalued by 36% .
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.